Don't Miss

Clinical Trials Update: Dec. 15, 2009

By HealthCast on December 15, 2009

Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Depression

This study seeks people diagnosed with depression that have not fully responded to an antidepressant medication. The study will evaluate newly developed brain imaging methods that will allow participants to help control brain activation.

The research site is in Menlo Park, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.

—–

Type 2 Diabetes (Metformin Users)

This study will evaluate the safety and tolerability of an investigational medication for type 2 diabetes. Participants will take daily capsules of the investigational drug along with their usual dose of Metformin.

The research site is in High Point, N.C.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.

—–

Metastatic Colorectal Cancer – PEAK Study

This study is for people with colorectal cancer that has metastasized (spread). The study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it extends survival.

The research site is in Indianapolis, Ind.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/colorectal_cancer.aspx.

—–

Source: HealthDay

Are You Living with Psoriasis?

A growing knowledge of the skin disease called psoriasis is leading to greater treatment choices, including personalized therapies, the U.S. Food and Drug Administration reports.

Psoriasis is an immune system disorder that causes overproduction of skin cells, resulting in scaling, pain, swelling, redness and heat. The condition affects about 7.5 million Americans.

“As we better understand the disease, researchers know more about what specific factors to target in order to develop effective treatments,” FDA dermatologist Dr. Melinda McCord said in an agency news release.

There is no cure for psoriasis, so the main goals of treatments are to stop skin cell overproduction and reduce inflammation. Current therapies include medicines applied to the skin (topical), light treatment (phototherapy), or drugs taken by mouth or given by injection.

Doctors used to take a step-by-step approach, starting patients with mild to moderate psoriasis on topical therapy. If that was ineffective, doctors moved on to phototherapy or drug treatment.

Clinical Trials Update: Dec. 15, 2009

Leave a Reply

Are You Living with Psoriasis?

Cancer

Pregnancy

General Health

Fitness & Exercise

Drugs & Medication

Kid's Health